Study of hidradenitis suppurativa skin features
Part of Infections, Skin clinical trials.
This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 13 years old or older
- You have been diagnosed with hidradenitis suppurativa by a doctor
- You (or your parent/guardian, if needed) can and are willing to give informed consent
- If you do not have HS, you must not have any long-term skin conditions
- If you do not have HS, you must not have used antibiotics recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study explores how people with hidradenitis suppurativa (HS) participate in research. You'll report your health regularly using a device, and the goal is to better understand patient experiences.
This study enrolls people with hidradenitis suppurativa (HS) to better understand the condition over time and store optional health information and samples. Being in the registry may help researchers learn about patterns in HS and support future research.
This study looks at what causes hidradenitis suppurativa (HS) in the body. It may help researchers understand the condition better and could lead to better treatments.
This study looks at how skin cells work in people with hidradenitis suppurativa (HS), a condition that causes painful lumps under the skin. It aims to understand the disease better, which might lead to improved treatments in the future.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
This trial tests an immune-focused treatment strategy for adults with moderate-to-severe hidradenitis suppurativa (HS), especially for cases where surgery is needed. If eligible, you may get a planned study treatment and be compared to a group without HS undergoing a related surgery.
Hear when a new Hidradenitis Suppurativa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.